BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 11806985)

  • 1. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.
    Onida F; Kantarjian HM; Smith TL; Ball G; Keating MJ; Estey EH; Glassman AB; Albitar M; Kwari MI; Beran M
    Blood; 2002 Feb; 99(3):840-9. PubMed ID: 11806985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
    Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
    Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical Characteristics and Survival Analysis of Patients with Chronic Myelomonocytic Leukemia].
    Wang JY; Chen JF; Wang SF; Guo QH; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):476-482. PubMed ID: 37096522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myelomonocytic leukemia with antecedent refractory anemia with excess blasts: further evidence for the arbitrary nature of current classification systems.
    Breccia M; Cannella L; Frustaci A; Stefanizzi C; D'Elia GM; Alimena G
    Leuk Lymphoma; 2008 Jul; 49(7):1292-6. PubMed ID: 18604717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].
    Germing U; Strupp C; Meckenstock G; Giagounidis A; Minning H; Aul C
    Med Klin (Munich); 1999 Sep; 94(9):467-72. PubMed ID: 10544608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group.
    Wattel E; Guerci A; Hecquet B; Economopoulos T; Copplestone A; Mahé B; Couteaux ME; Resegotti L; Voglova V; Foussard C; Pegourié B; Michaux JL; Deconinck E; Stoppa AM; Mufti G; Oscier D; Fenaux P
    Blood; 1996 Oct; 88(7):2480-7. PubMed ID: 8839839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment in chronic myelomonocytic leukemia (CMML).
    Germing U; Kündgen A; Gattermann N
    Leuk Lymphoma; 2004 Jul; 45(7):1311-8. PubMed ID: 15359628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes.
    Patnaik MM; Padron E; LaBorde RR; Lasho TL; Finke CM; Hanson CA; Hodnefield JM; Knudson RA; Ketterling RP; Al-kali A; Pardanani A; Ali NA; Komrokji RS; Tefferi A
    Leukemia; 2013 Jul; 27(7):1504-10. PubMed ID: 23531518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of chronic myelomonocytic leukemia.
    Catalano L; Improta S; de Laurentiis M; Molica S; Majolino I; Musto P; Fragasso A; De Placido S; Rotoli B
    Haematologica; 1996; 81(4):324-9. PubMed ID: 8870376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems in the classification of CMML--dysplastic versus proliferative type.
    Germing U; Gattermann N; Minning H; Heyll A; Aul C
    Leuk Res; 1998 Oct; 22(10):871-8. PubMed ID: 9766745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System.
    Beran M; Wen S; Shen Y; Onida F; Jelinek J; Cortes J; Giles F; Kantarjian H
    Leuk Lymphoma; 2007 Jun; 48(6):1150-60. PubMed ID: 17577778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2024 Jun; 99(6):1142-1165. PubMed ID: 38450850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of Prognostication in Chronic Myelomonocytic Leukemia.
    Onida F
    Curr Hematol Malig Rep; 2017 Dec; 12(6):513-521. PubMed ID: 29064026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
    Pleyer L; Leisch M; Kourakli A; Padron E; Maciejewski JP; Xicoy Cirici B; Kaivers J; Ungerstedt J; Heibl S; Patiou P; Hunter AM; Mora E; Geissler K; Dimou M; Jimenez Lorenzo MJ; Melchardt T; Egle A; Viniou AN; Patel BJ; Arnan M; Valent P; Roubakis C; Bernal Del Castillo T; Galanopoulos A; Calabuig Muñoz M; Bonadies N; Medina de Almeida A; Cermak J; Jerez A; Montoro MJ; Cortés A; Avendaño Pita A; Lopez Andrade B; Hellstroem-Lindberg E; Germing U; Sekeres MA; List AF; Symeonidis A; Sanz GF; Larcher-Senn J; Greil R
    Lancet Haematol; 2021 Feb; 8(2):e135-e148. PubMed ID: 33513373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2013 Nov; 88(11):967-74. PubMed ID: 23963888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia.
    Such E; Germing U; Malcovati L; Cervera J; Kuendgen A; Della Porta MG; Nomdedeu B; Arenillas L; Luño E; Xicoy B; Amigo ML; Valcarcel D; Nachtkamp K; Ambaglio I; Hildebrandt B; Lorenzo I; Cazzola M; Sanz G
    Blood; 2013 Apr; 121(15):3005-15. PubMed ID: 23372164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of monocytosis in patients with myeloproliferative disorders.
    Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E
    Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations.
    Gur HD; Loghavi S; Garcia-Manero G; Routbort M; Kanagal-Shamanna R; Quesada A; Khogeer H; Pierce S; Medeiros LJ; Kantarjian H; Khoury JD
    Am J Surg Pathol; 2018 Jun; 42(6):799-806. PubMed ID: 29596070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
    Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W
    Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2020 Jan; 95(1):97-115. PubMed ID: 31736132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.